ID   TESK1_RAT               Reviewed;         628 AA.
AC   Q63572;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   24-JUL-2024, entry version 178.
DE   RecName: Full=Dual specificity testis-specific protein kinase 1;
DE            EC=2.7.12.1;
DE   AltName: Full=Testicular protein kinase 1;
GN   Name=Tesk1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Testis;
RX   PubMed=8537404; DOI=10.1074/jbc.270.52.31331;
RA   Toshima J., Ohashi K., Okano I., Nunoue K., Kishioka M., Kuma K.,
RA   Miyata T., Hirai M., Baba T., Mizuno K.;
RT   "Identification and characterization of a novel protein kinase, TESK1,
RT   specifically expressed in testicular germ cells.";
RL   J. Biol. Chem. 270:31331-31337(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION, TISSUE SPECIFICITY, PHOSPHORYLATION AT SER-215, ACTIVITY
RP   REGULATION, AND MUTAGENESIS OF ASP-170; TYR-201; SER-215 AND TYR-217.
RX   PubMed=10207045; DOI=10.1074/jbc.274.17.12171;
RA   Toshima J., Tanaka T., Mizuno K.;
RT   "Dual specificity protein kinase activity of testis-specific protein kinase
RT   1 and its regulation by autophosphorylation of serine-215 within the
RT   activation loop.";
RL   J. Biol. Chem. 274:12171-12176(1999).
RN   [4]
RP   FUNCTION, INTERACTION WITH YWHAB, PHOSPHORYLATION AT SER-439, AND
RP   MUTAGENESIS OF ASP-170 AND SER-439.
RX   PubMed=11555644; DOI=10.1074/jbc.m104620200;
RA   Toshima J.Y., Toshima J., Watanabe T., Mizuno K.;
RT   "Binding of 14-3-3beta regulates the kinase activity and subcellular
RT   localization of testicular protein kinase 1.";
RL   J. Biol. Chem. 276:43471-43481(2001).
RN   [5]
RP   INTERACTION WITH PARVA.
RX   PubMed=15817463; DOI=10.1074/jbc.m500752200;
RA   LaLonde D.P., Brown M.C., Bouverat B.P., Turner C.E.;
RT   "Actopaxin interacts with TESK1 to regulate cell spreading on
RT   fibronectin.";
RL   J. Biol. Chem. 280:21680-21688(2005).
RN   [6]
RP   INTERACTION WITH SPRED1; SPRY1; SPRY2; SPRY3; SPRY4 AND SPRED2, AND
RP   MUTAGENESIS OF ASP-170.
RX   PubMed=17974561; DOI=10.1074/jbc.m705457200;
RA   Chandramouli S., Yu C.Y., Yusoff P., Lao D.H., Leong H.F., Mizuno K.,
RA   Guy G.R.;
RT   "Tesk1 interacts with Spry2 to abrogate its inhibition of ERK
RT   phosphorylation downstream of receptor tyrosine kinase signaling.";
RL   J. Biol. Chem. 283:1679-1691(2008).
RN   [7]
RP   FUNCTION, ACTIVITY REGULATION, INTERACTION WITH TAOK1 AND SPRED1, AND
RP   MUTAGENESIS OF ASP-170.
RX   PubMed=18216281; DOI=10.1091/mbc.e07-07-0730;
RA   Johne C., Matenia D., Li X.Y., Timm T., Balusamy K., Mandelkow E.M.;
RT   "Spred1 and TESK1--two new interaction partners of the kinase MARKK/TAO1
RT   that link the microtubule and actin cytoskeleton.";
RL   Mol. Biol. Cell 19:1391-1403(2008).
RN   [8]
RP   SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY CELL ADHESION
RP   AND SCIATIC NERVE CRUSH INJURY.
RX   PubMed=22302232; DOI=10.1007/s12031-012-9712-x;
RA   Lou D., Sun B., Wei H., Deng X., Chen H., Xu D., Li G., Xu H., Wang Y.;
RT   "Spatiotemporal expression of testicular protein kinase 1 after rat sciatic
RT   nerve injury.";
RL   J. Mol. Neurosci. 47:180-191(2012).
CC   -!- FUNCTION: Dual specificity protein kinase activity catalyzing
CC       autophosphorylation and phosphorylation of exogenous substrates on both
CC       serine/threonine and tyrosine residues (PubMed:10207045). Regulates the
CC       cellular cytoskeleton by enhancing actin stress fiber formation via
CC       phosphorylation of cofilin and by preventing microtubule breakdown via
CC       inhibition of TAOK1/MARKK kinase activity (PubMed:11555644,
CC       PubMed:18216281). Inhibits podocyte motility via regulation of actin
CC       cytoskeletal dynamics and phosphorylation of CFL1 (By similarity).
CC       Positively regulates integrin-mediated cell spreading, via
CC       phosphorylation of cofilin (By similarity). Suppresses ciliogenesis via
CC       multiple pathways; phosphorylation of CFL1, suppression of ciliary
CC       vesicle directional trafficking to the ciliary base, and by
CC       facilitating YAP1 nuclear localization where it acts as a
CC       transcriptional corepressor of the TEAD4 target genes AURKA and PLK1
CC       (By similarity). Probably plays a central role at and after the meiotic
CC       phase of spermatogenesis (PubMed:8537404).
CC       {ECO:0000250|UniProtKB:O70146, ECO:0000250|UniProtKB:Q15569,
CC       ECO:0000269|PubMed:10207045, ECO:0000269|PubMed:11555644,
CC       ECO:0000269|PubMed:18216281, ECO:0000269|PubMed:8537404}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.12.1;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-tyrosyl-[protein] = ADP + H(+) + O-phospho-L-tyrosyl-
CC         [protein]; Xref=Rhea:RHEA:10596, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620, ChEBI:CHEBI:456216; EC=2.7.12.1;
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC   -!- ACTIVITY REGULATION: Activated by autophosphorylation on Ser-215.
CC       Kinase activity is inhibited by SPRED1. {ECO:0000269|PubMed:10207045,
CC       ECO:0000269|PubMed:18216281}.
CC   -!- SUBUNIT: Interacts (via both C- and N-termini) with SPRY4 (via C-
CC       terminus); the interaction inhibits TESK1 kinase activity
CC       (PubMed:17974561). Interacts with TAOK1; the interaction inhibits TAOK1
CC       kinase activity (PubMed:18216281). Interacts (via C-terminus) with
CC       SPRED1 (via C-terminus); the interaction inhibits TESK1 kinase activity
CC       (PubMed:17974561, PubMed:18216281). Interacts (via C-terminus) with
CC       PARVA/PARVIN (via C-terminus); the interaction inhibits TESK1 kinase
CC       activity (PubMed:15817463). Interacts with YWHAB/14-3-3 beta; the
CC       interaction is dependent on the phosphorylation of TESK1 Ser-439 and
CC       inhibits TESK1 kinase activity (PubMed:11555644). Interacts with SPRY1,
CC       SPRY3 and SPRED2 (PubMed:17974561). Interacts (via C-terminus) with
CC       SPRY2 (via C-terminus); the interaction disrupts SPRY2 interaction with
CC       PPP2CA/PP2A-C, possibly by vesicular sequestration of SPRY2
CC       (PubMed:17974561). Therefore dephosphorylation of SPRY2 by the
CC       serine/threonine-protein phosphatase 2A (PP2A) holoenzyme is lost,
CC       inhibiting its interaction with GRB2 (PubMed:17974561).
CC       {ECO:0000269|PubMed:11555644, ECO:0000269|PubMed:15817463,
CC       ECO:0000269|PubMed:17974561, ECO:0000269|PubMed:18216281}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:22302232}.
CC       Cytoplasm, perinuclear region {ECO:0000269|PubMed:22302232}. Cytoplasm,
CC       cytoskeleton, microtubule organizing center, centrosome
CC       {ECO:0000250|UniProtKB:Q15569}. Cell projection, lamellipodium
CC       {ECO:0000269|PubMed:22302232}. Note=Colocalizes with SPRY4 in vesicular
CC       spots in the cytoplasm (By similarity). Localized to F-actin-rich
CC       lamellipodia at the cell periphery following fibronectin-mediated cell
CC       adhesion of Schwann cells (PubMed:22302232).
CC       {ECO:0000250|UniProtKB:Q15569, ECO:0000269|PubMed:22302232}.
CC   -!- TISSUE SPECIFICITY: Weakly expressed in sciatic nerves (at protein
CC       level) (PubMed:22302232). Highly expressed in testicular germ cells
CC       (PubMed:10207045, PubMed:8537404). Expressed at low levels in brain,
CC       lung, heart, liver and kidney (PubMed:10207045).
CC       {ECO:0000269|PubMed:10207045, ECO:0000269|PubMed:22302232,
CC       ECO:0000269|PubMed:8537404}.
CC   -!- INDUCTION: Induced by fibronectin-mediated cell adhesion of Schwann
CC       cells (PubMed:22302232). Induced by sciatic nerve crush injury,
CC       expression peaks 2 weeks post-injury and returns to normal at 4 weeks
CC       post-injury in the macrophages of promyelinating Schwann tubules
CC       (PubMed:22302232). {ECO:0000269|PubMed:22302232}.
CC   -!- DOMAIN: The extracatalytic C-terminal part is highly rich in proline
CC       residues.
CC   -!- PTM: Autophosphorylated on serine and tyrosine residues.
CC       {ECO:0000269|PubMed:10207045}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. TKL Ser/Thr
CC       protein kinase family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D50864; BAA09460.1; -; mRNA.
DR   EMBL; BC081773; AAH81773.1; -; mRNA.
DR   RefSeq; NP_113766.1; NM_031578.1.
DR   AlphaFoldDB; Q63572; -.
DR   SMR; Q63572; -.
DR   MINT; Q63572; -.
DR   STRING; 10116.ENSRNOP00000071965; -.
DR   iPTMnet; Q63572; -.
DR   PhosphoSitePlus; Q63572; -.
DR   PaxDb; 10116-ENSRNOP00000023694; -.
DR   Ensembl; ENSRNOT00000080909.2; ENSRNOP00000071965.1; ENSRNOG00000053729.2.
DR   Ensembl; ENSRNOT00055028670; ENSRNOP00055023093; ENSRNOG00055016877.
DR   Ensembl; ENSRNOT00060007993; ENSRNOP00060005982; ENSRNOG00060004800.
DR   Ensembl; ENSRNOT00065015695; ENSRNOP00065011864; ENSRNOG00065009759.
DR   GeneID; 29460; -.
DR   KEGG; rno:29460; -.
DR   UCSC; RGD:62059; rat.
DR   AGR; RGD:62059; -.
DR   CTD; 7016; -.
DR   RGD; 62059; Tesk1.
DR   eggNOG; ENOG502QTCP; Eukaryota.
DR   GeneTree; ENSGT00940000157807; -.
DR   HOGENOM; CLU_018577_0_0_1; -.
DR   InParanoid; Q63572; -.
DR   OMA; SPPTWGD; -.
DR   OrthoDB; 5474815at2759; -.
DR   PhylomeDB; Q63572; -.
DR   TreeFam; TF318014; -.
DR   BRENDA; 2.7.10.2; 5301.
DR   Reactome; R-RNO-446388; Regulation of cytoskeletal remodeling and cell spreading by IPP complex components.
DR   PRO; PR:Q63572; -.
DR   Proteomes; UP000002494; Chromosome 5.
DR   Bgee; ENSRNOG00000053729; Expressed in testis and 19 other cell types or tissues.
DR   GO; GO:0005813; C:centrosome; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0030027; C:lamellipodium; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:ARUK-UCL.
DR   GO; GO:0106310; F:protein serine kinase activity; IEA:RHEA.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; IMP:RGD.
DR   GO; GO:0004712; F:protein serine/threonine/tyrosine kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IBA:GO_Central.
DR   GO; GO:0051650; P:establishment of vesicle localization; ISS:UniProtKB.
DR   GO; GO:1902018; P:negative regulation of cilium assembly; ISS:UniProtKB.
DR   GO; GO:0042326; P:negative regulation of phosphorylation; ISS:UniProtKB.
DR   GO; GO:0031953; P:negative regulation of protein autophosphorylation; IDA:ARUK-UCL.
DR   GO; GO:0071901; P:negative regulation of protein serine/threonine kinase activity; IDA:ARUK-UCL.
DR   GO; GO:0090521; P:podocyte cell migration; ISS:UniProtKB.
DR   GO; GO:1900182; P:positive regulation of protein localization to nucleus; ISS:UniProtKB.
DR   GO; GO:0001934; P:positive regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:0051496; P:positive regulation of stress fiber assembly; IDA:ARUK-UCL.
DR   GO; GO:1900026; P:positive regulation of substrate adhesion-dependent cell spreading; ISS:UniProtKB.
DR   GO; GO:0032956; P:regulation of actin cytoskeleton organization; ISO:RGD.
DR   GO; GO:0032880; P:regulation of protein localization; IDA:ARUK-UCL.
DR   GO; GO:0007283; P:spermatogenesis; IEP:RGD.
DR   CDD; cd14155; PKc_TESK; 1.
DR   Gene3D; 1.10.510.10; Transferase(Phosphotransferase) domain 1; 1.
DR   InterPro; IPR050940; Actin_reg-Ser/Thr_kinase.
DR   InterPro; IPR011009; Kinase-like_dom_sf.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr_kinase_cat_dom.
DR   InterPro; IPR008266; Tyr_kinase_AS.
DR   PANTHER; PTHR46485:SF3; DUAL SPECIFICITY TESTIS-SPECIFIC PROTEIN KINASE 1; 1.
DR   PANTHER; PTHR46485; LIM DOMAIN KINASE 1; 1.
DR   Pfam; PF07714; PK_Tyr_Ser-Thr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   SUPFAM; SSF56112; Protein kinase-like (PK-like); 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   ATP-binding; Cell projection; Cytoplasm; Cytoskeleton; Kinase; Magnesium;
KW   Manganese; Metal-binding; Methylation; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Serine/threonine-protein kinase; Transferase;
KW   Tyrosine-protein kinase.
FT   CHAIN           1..628
FT                   /note="Dual specificity testis-specific protein kinase 1"
FT                   /id="PRO_0000086748"
FT   DOMAIN          52..310
FT                   /note="Protein kinase"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   REGION          1..35
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          330..376
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          421..526
FT                   /note="Required for interaction with YWHAB"
FT                   /evidence="ECO:0000269|PubMed:11555644"
FT   REGION          424..490
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          529..628
FT                   /note="Required for interaction with SPRED1 and SPRY2.
FT                   Required for TESK1-mediated dephosphorylation of SPRY2 and
FT                   SPRY2 inhibition of ERK phosphorylation"
FT                   /evidence="ECO:0000269|PubMed:17974561"
FT   REGION          529..626
FT                   /note="Required for interaction with PARVA"
FT                   /evidence="ECO:0000269|PubMed:15817463"
FT   REGION          538..568
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        170
FT                   /note="Proton acceptor"
FT   BINDING         58..66
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   BINDING         81
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00159"
FT   MOD_RES         215
FT                   /note="Phosphoserine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:10207045"
FT   MOD_RES         338
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:O70146"
FT   MOD_RES         439
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:11555644"
FT   MUTAGEN         170
FT                   /note="D->A: Loss of kinase and autophosphorylating
FT                   activity. Abolishes TESK1-induced actin stress fiber
FT                   formation. No effect on interaction with YWHAB, SPRY2 or
FT                   SPRED1. No effect on TESK1-mediated dephosphorylation of
FT                   SPRY2."
FT                   /evidence="ECO:0000269|PubMed:10207045,
FT                   ECO:0000269|PubMed:11555644, ECO:0000269|PubMed:17974561,
FT                   ECO:0000269|PubMed:18216281"
FT   MUTAGEN         201
FT                   /note="Y->A: No effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:10207045"
FT   MUTAGEN         215
FT                   /note="S->A: Loss of autophosphorylation site, loss of
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:10207045"
FT   MUTAGEN         215
FT                   /note="S->E: Loss of autophosphorylation site, no effect on
FT                   kinase activity."
FT                   /evidence="ECO:0000269|PubMed:10207045"
FT   MUTAGEN         217
FT                   /note="Y->A: No effect on autophosphorylation."
FT                   /evidence="ECO:0000269|PubMed:10207045"
FT   MUTAGEN         439
FT                   /note="S->A: Abolishes interaction with YWHAB."
FT                   /evidence="ECO:0000269|PubMed:11555644"
SQ   SEQUENCE   628 AA;  67988 MW;  F05F67FBD934B9AD CRC64;
     MAGERPPLRG PGPGETPVEG PGGAGGGPGR GRPSSYRALR SAVSSLARVD DFDCAEKIGA
     GFFSEVYKVR HRQSGQVMVL KMNKLPSNRS NTLREVQLMN RLRHPNILRF MGVCVHQGQL
     HALTEYMNGG TLEQLLSSPE PLSWPVRLHL ALDIAQGLRY LHAKGVFHRD LTSKNCLVRR
     EDGGFTAVVG DFGLAEKIPV YREGARKEPL AVVGSPYWMA PEVLRGELYD EKADVFAFGI
     VLCELIARVP ADPDYLPRTE DFGLDVPAFR TLVGNDCPLP FLLLAIHCCS MEPSARAPFT
     EITQHLEQIL EQLPEPTPLA KMPLAKAPLT YNQGSVPRGG PSATLPRSDP RLSRSRSDLF
     LPPSPESPPS WGDNLTRVNP FSLREDLRGG KIKLLDTPCK PATPLPLVPP SPLTSTQLPL
     VASPESLVQP ETPVRRCRSL PSSPELPRRM ETALPGPGPS PVGPSTEERM DCEGSSPEPE
     PPGPAPQLPL AVATDNFIST CSSASQPWSA RPGPSLNNNP PAVVVNSPQG WAREPWNRAQ
     HSLPRAAALE RTEPSPPPSA PREQEEGLPC PGCCLSPFSF GFLSMCPRPT PAVARYRNLN
     CEAGSLLCHR GHHAKPPTPS LQLPGARS
//
